In order for an abstract to be accepted for presentation, the presenting author must pay the full registration fee. Registration fee payment deadline for inclusion of the abstract in the Programme: 28 February 2022.
The deadline for submitting abstracts is 10 December 2021.
Only Accepted abstracts that are submitted in the period from 14 June 2021 to 28 February 2022 will be included in the Programme.
Method of submission
- All abstracts must be submitted via the Abstract Portal that is accessible after Login.
- The submitting author of the abstract must be a presenting author ("the submitting author = the presenting author").
- The submitting (= presenting) author does not have to be the first author.
- Authors will be notified about the receipt of their abstract by e-mail immediately. In case you did not receive confirmation within 24 hours, please check your spam folder, otherwise please contact: firstname.lastname@example.org
- Authors will be able to edit their abstracts before the submission deadline. After this period, the abstract will be locked and sent to reviewers.
- All correspondences concerning submitted abstract will be sent via email to submitting author’s e-mail address.
- The length of the abstracts in plain text should not exceed 300 words.
- itle: Make the title of the abstract brief, clearly indicating the nature of the work to be presented. Use a capital letter for the first letter of the title only (DO NOT capitalize each word).
- Names of the authors: Submit the full given name(s) and the family name. Do not include degrees or professional titles.
Conflict of interest
When an author or the institution of the author has a relationship, financial or otherwise, with individuals or organizations that could influence the author’s work inappropriately, a conflict of interest may exist.
Examples of potential conflicts of interest may include but are not limited to academic, personal, or political relationships; employment; consultancies or honoraria; and finical connections such as stock ownership and funding. Although an author may not feel that there are conflicts, disclosure of relationships and interests that could be viewed by others as conflicts of interest affords a more transparent and prudent process. All authors must disclose any actual or potential conflict of interest. The Book of Abstracts will publish such disclosures if judged to be important to readers.
Statement of informed consent
Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the abstract/manuscript to be published or in presentation slides.
Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.
Statement of Data Protection Regulations
In compliance with the European data protection regulations, IUPESM WC 2022 and the Secretariat will not share any of the information received in the context of this form with any third parties and will use the information only in the context of IUPESM WC 2022. No other use will be made of your data without your explicit written permission.
Statement of human and animal rights
When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 and 2008. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.
If you have any questions regarding abstract submission, please contact email@example.com